Skip To Content

ACD/Labs Blog

Joel Michalski
In this article Ruairi Mackenzie speaks with ACD/Labs’ Andrew Anderson about Anderson’s unique vantage point into how technology affects the analytical chemistry field. Read on for a discussion of how the day-to-day life of a chemist has been changed by technologies like AI and automation and how budding chemists can get their skillset up to...

Andrew Anderson
What will the Lab of the Future look like? Andrew Anderson offers his insights into how ACD/Labs is poised to deliver products and capabilities to help usher companies into this unknown future.

Joel Michalski
This guide to informatics and data integrity published by the European Pharmaceutical Review highlights ACD/Labs software solutions including our Spectrus and Percepta platforms, and new solutions Luminata and Katalysts D2D.

Joel Michalski
Efficient design, planning, execution, and analysis of catalyst screening experiments can present a significant productivity challenge to process chemistry groups. Katalyst D2D provides scientists with a single application interface to effectively identify catalytic conditions for process routes of interest as efficiently as possible.

Andrew Anderson
For scientists involved in pharmaceutical development, high throughput experimentation is commonplace. While there are many observed benefits with HTE workflows, there are also significant impediments to its utilization. The industry requires a technological solution that can help streamline workflows and demonstrate data integrity. That's why we've recently launched Katalyst D2D.

Sherry Myles
New software facilitates the design, planning, execution and analysis of high throughput experiments to optimize the efficiency of product development—from Design to Decide Toronto, Canada (March 19, 2019)—ACD/Labs, an informatics company that is celebrating 25 years of providing analytical and chemical knowledge management solutions for R&D, today announced the launch of a new web-based application...